Docket Number:10A-1040316
Inventor:Jyh-Yih Chen, Chang-Jer Wu
IP Status:US 9,925,235 B2、TW I610682、CN 106063929 B
Abstract:
Tilapia piscidin 3 (TP3) and tilapia piscidin 4 (TP4) are antimicrobial peptides (AMPs) isolated from Nile tilapia, represent promising agents for new therapeutic approaches of infected wound treatment, on account of their antimicrobial and wound closure activities, and low potential for inducing resistance. AMPs are anti-inflammatory, anti-septic, anti-bacterial, and wound-tissue regenerating, they promote wound healing rates. AMPs may be suitable for development as a novel topical agent for treatment of infected wounds.
Fields of Application:
AMPs of TP3 and TP4 may be suitable for development as a novel topical agent for treatment of infected wounds, such as wounds slowly forming a hard crust, promote wound healing and minimise the risk of infection.
Advantages when compared to the existing technologies:
Antimicrobial peptides have broad spectrum antibacterial activity in organisms. They are not affected by traditional antibiotic resistance mutant strains and do not easily produce drug-resistant strains. That can replace traditional antibiotics to use, in the future as humans burn wound treatment on the swing, it seems worth looking forward to space.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
